NCT01234311_2B: NCT01234311, figure 2B

NCT01234311_2BR Documentation

NCT01234311, figure 2B

Description

Kaplan-Meier digitized data from NCT01234311, figure 2B (PMID 27298414). A reported sample size of 1,245 for a primary endpoint of rPFS in prostate cancer.

Usage

NCT01234311_2B

Format

A data frame of 1,158 observations and 3 variables:

time event time (in months)
event OS event indicator (0: no event, 1: event)
arm treatment arms (placebo, tasq)

Source

Sternberg C, Armstrong A, Pili R, et al. Randomized, Double-Blind, Placebo-Controlled Phase III Study of Tasquinimod in Men With Metastatic Castration-Resistant Prostate Cancer. J Clin Oncol 2016; 34: 2636–43.

Examples

summary(NCT01234311_2B)

kmplot(NCT01234311_2B)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.